Xenon Pharmaceuticals Inc. - Common Stock (XENE)

Historical Holders from Q4 2014 to Q3 2025

Symbol
XENE on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
77.3M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
84.3M
Holdings value
$3.39B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
216
Number of buys
98
Number of sells
-92
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Xenon Pharmaceuticals Inc. - Common Stock (XENE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 11.5% +12% $277M $30.6M 8.82M +12.4% FMR LLC 30 Jun 2025
BlackRock, Inc. 6.2% $149M 4.76M BlackRock, Inc. 30 Jun 2025
JANUS HENDERSON GROUP PLC 5.1% $158M 3.94M JANUS HENDERSON GROUP PLC 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 2.8% $68.3M 2.17M Wellington Management Group LLP 30 Jun 2025

Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 84.3M $3.39B +$50.8M $40.15 216
2025 Q2 83.1M $2.6B +$191M $31.30 206
2025 Q1 76.7M $2.58B +$10.2M $33.55 206
2024 Q4 76.3M $2.99B +$29.9M $39.20 209
2024 Q3 74.9M $2.95B +$276K $39.37 202
2024 Q2 74.2M $2.89B +$26M $38.99 212
2024 Q1 73.5M $3.16B +$66.7M $43.05 220
2023 Q4 72.1M $3.32B +$474M $46.06 204
2023 Q3 61.4M $2.1B +$8.68M $34.16 180
2023 Q2 61.3M $2.36B +$10.9M $38.50 173
2023 Q1 61.1M $2.19B +$24.6M $35.79 161
2022 Q4 60.5M $2.38B +$38.7M $39.43 157
2022 Q3 58M $2.09B +$39.5M $36.10 151
2022 Q2 57M $1.73B +$237M $30.42 149
2022 Q1 49M $1.5B +$45M $30.57 128
2021 Q4 47.7M $1.49B +$454M $31.24 129
2021 Q3 34.1M $521M +$348K $15.28 113
2021 Q2 33.3M $620M +$2.57M $18.62 99
2021 Q1 33M $590M +$88.8M $17.90 88
2020 Q4 28M $431M -$1.91M $15.38 79
2020 Q3 27.9M $309M -$547K $11.07 79
2020 Q2 28M $351M +$8.43M $12.54 78
2020 Q1 27.7M $314M +$101M $11.34 69
2019 Q4 18.7M $245M +$22.4M $13.11 66
2019 Q3 16.1M $145M -$14.7M $9.01 53
2019 Q2 17.6M $173M -$1.95M $9.86 59
2019 Q1 17.7M $180M +$3M $10.16 61
2018 Q4 17.5M $110M -$24.4M $6.31 56
2018 Q3 17.7M $234M +$115M $13.20 59
2018 Q2 9.04M $83.2M +$29.1M $9.20 41
2018 Q1 6.35M $31.1M -$13.8M $4.90 35
2017 Q4 9.16M $25.9M -$498K $2.83 31
2017 Q3 9.32M $27.5M -$1.98M $2.95 31
2017 Q2 9.95M $31.3M -$1.14M $3.15 39
2017 Q1 10.1M $40.3M -$3.17M $4.00 37
2016 Q4 10.5M $80.8M +$1.87M $7.70 31
2016 Q3 9.94M $80.6M +$37M $8.10 31
2016 Q2 5.38M $32M -$2.51M $5.90 21
2016 Q1 5.71M $39.9M -$1.43M $6.99 25
2015 Q4 5.78M $46.5M +$2.27M $8.04 25
2015 Q3 5.48M $45.2M +$5.12M $8.26 25
2015 Q2 4.81M $55.4M +$3.17M $11.53 25
2015 Q1 4.45M $75.2M +$2.92M $16.86 23
2014 Q4 4.28M $83.1M +$76.7M $19.75 16